Back to Search Start Over

Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A).

Authors :
Graffmann N
Martins S
Ljubikj T
Matte JC
Bohndorf M
Wruck W
Adjaye J
Source :
Stem cell research [Stem Cell Res] 2021 Mar; Vol. 51, pp. 102167. Date of Electronic Publication: 2021 Jan 12.
Publication Year :
2021

Abstract

Human fibroblasts cells from a Crigler-Najjar Syndrome (CNS) patient were used to generate integration-free induced pluripotent stem cells (iPSCs) by over-expressing episomal-based plasmids expressing OCT4, SOX2, NANOG, KLF4, c-MYC and LIN28. The derived CNS705-iPSC line is homozygous for the UGT1A1 c.877_890delTACATTAATGCTTCinsA mutation. Pluripotency was confirmed by the expression of associated markers and embryoid body-based differentiation into cell types from all three germ layers. Comparative transcriptome analysis of the iPSC and the human embryonic stem cell line H9 revealed a Pearson's correlation of 0.9468.<br /> (Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1876-7753
Volume :
51
Database :
MEDLINE
Journal :
Stem cell research
Publication Type :
Academic Journal
Accession number :
33485181
Full Text :
https://doi.org/10.1016/j.scr.2021.102167